The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...
Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.
The cancer antigen therapy mRNA-4359 yielded a high rate of antitumor responses in combination with pembrolizumab (Keytruda) ...
An mRNA vaccine for pancreatic cancer is showing long-term results in an early-stage clinical trial. Still in its ...
India Today on MSN
Pancreatic cancer vaccine shows long-term survival promise
If larger trials succeed, personalized mRNA vaccines could finally turn pancreatic cancer from a near-certain killer into a ...
Some promising things are happening in health news, including a possible personalized vaccine against pancreatic cancer. Hear ...
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally, the Company will host a conference call ...
Morning Overview on MSN
MRNA vaccine trial shows lasting gains for some pancreatic cancer patients
When Vinod Balachandran and his colleagues at Memorial Sloan Kettering Cancer Center first reported in 2023 that a ...
Explore innovative ways to treat pancreatic cancer, including personalized mRNA vaccines designed to target tumor cells ...
Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...
Neoadjuvant or perioperative immunotherapy, either alone or in combination with other antineoplastic agents (e.g., chemotherapy), has been shown to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results